T3	Condition-Name 336 343	illness
T4	Condition 347 363	medical disorder
T5	Condition-Name 347 363	medical disorder
E4	Condition:T4 Name:T5
T6	Procedure 503 522	Typhoid vaccination
T7	Procedure-Name 503 522	Typhoid vaccination
E6	Procedure:T6 Name:T7 Temporality:E39
T8	Condition 589 606	Typhoid infection
T9	Condition-Name 589 606	Typhoid infection
E8	Condition:T8 Name:T9 Temporality:E29 Temporality2:E40
T10	Condition 661 664	HCV
T11	Condition-Name 661 664	HCV
E10	Condition:T10 Name:T11 Polarity:T57
T13	Eq-Temporal-Unit 140 145	years
A2	Eq-Temporal-Unit-Value T13 year
T14	Eq-Temporal-Unit 625 631	months
A3	Eq-Temporal-Unit-Value T14 month
T15	Age 126 130	aged
E11	Age:T15 Eq-Comparison:E12
T16	Eq-Operator 134 136	to
A4	Eq-Operator-Value T16 BETWEEN
T17	Eq-Value 131 133	18
T18	Eq-Value 137 139	55
T19	Eq-Value 623 624	6
T20	Eq-Comparison 131 145	18 to 55 years
E12	Eq-Comparison:T20 Operator:T16 Value:T17 Value2:T18 Temporal-Unit:T13
T1	Life-Stage-And-Gender 39 42	men
A5	Life-Stage-And-Gender-Type T1 male
T21	Life-Stage-And-Gender 33 38	adult
A6	Life-Stage-And-Gender-Type T21 adult
T22	Life-Stage-And-Gender 46 51	women
A7	Life-Stage-And-Gender-Type T22 female
T23	Or 43 45	or
E1	Or:T23 Arg:T1 Arg2:T22
T24	Condition 64 72	pregnant
E3	Condition:T24 Name:T25
T25	Condition-Name 64 72	pregnant
T26	Negation 60 63	not
E5	Negation:T26 Negates:E3
T27	And 52 55	who
E7	And:T27 Arg:T22 Arg2:E5
T28	Condition 95 103	pregnant
E9	Condition:T28 Name:T29
T29	Condition-Name 95 103	pregnant
T30	Assertion 76 87	planning to
E13	Assertion:T30 Asserted:E9
A8	Assertion-Type-Value E13 hypothetical
T31	Study 111 116	study
E14	Study:T31 
T32	Temporal-Connection 104 110	during
E15	Temporal-Connection:T32 Arg:E9 Arg2:E14
A9	Temporal-Connection-Type-Value E15 during
T12	Observation 161 182	laboratory parameters
E16	Observation:T12 Polarity:T33 Name:T34
T33	Polarity 190 196	normal
A1	Polarity-Value T33 normal
T34	Observation-Name 161 182	laboratory parameters
A10	Observation-Type-Value T34 lab
T35	Condition 336 343	illness
E17	Condition:T35 Name:T3 Temporality:E38
T2	Modifier 312 320	physical
E2	Modifier:T2 Modifies:T3
T36	Modifier 324 335	psychiatric
E18	Modifier:T36 Modifies:T3
T37	Or 321 323	or
E19	Or:T37 Arg:E2 Arg2:E18
T38	Or 344 346	or
E20	Or:T38 Arg:E17 Arg2:E4
T39	Procedure 378 387	treatment
E21	Procedure:T39 
R1	Treatment-For Arg1:E21 Arg2:E4	
T41	Condition 413 429	hypersensitivity
E23	Condition:T41 Name:T42
T42	Condition-Name 413 429	hypersensitivity
T43	Drug 449 456	product
E24	Drug:T43 
R2	Caused-By Arg1:E23 Arg2:E24	
T44	Observation 535 553	anti-Vi antibodies
E25	Observation:T44 Name:T45 Polarity:T48
T45	Observation-Name 535 553	anti-Vi antibodies
A12	Observation-Type-Value T45 lab
T46	Study 557 566	screening
E26	Study:T46 
T47	Temporal-Connection 554 556	at
E27	Temporal-Connection:T47 Arg:E25 Arg2:E26
A13	Temporal-Connection-Type-Value E27 during
T48	Polarity 526 534	elevated
A14	Polarity-Value T48 high
T49	Or 523 525	or
E28	Or:T49 Arg:E6 Arg2:E25
T50	Eq-Comparison 614 631	previous 6 months
E29	Eq-Comparison:T50 Temporal-Unit:T14 Value:T19 Temporal-Period:T51
T52	Condition 646 649	HIV
E30	Condition:T52 Name:T53 Polarity:T57
T53	Condition-Name 646 649	HIV
T54	Condition 651 656	HBsAg
E31	Condition:T54 Name:T55 Polarity:T57
T55	Condition-Name 651 656	HBsAg
T56	Or 658 660	or
E32	Or:T56 Arg:E31 Arg2:E10
T57	Polarity 637 645	Positive
A16	Polarity-Value T57 positive
T58	Condition 687 696	condition
E33	Condition:T58 
T59	Condition 700 711	abnormality
E34	Condition:T59 Name:T60
T60	Condition-Name 700 711	abnormality
T63	Assertion 754 757	may
E36	Assertion:T63 Asserted:T40
A17	Assertion-Type-Value E36 hypothetical
T64	Or 697 699	or
E37	Or:T64 Arg:E33 Arg2:E34
T40	Stability 758 768	compromise
A11	Stability-Value T40 change
T61	Observation 773 779	safety
E22	Observation:T61 Name:T62 Stability:T40
T62	Observation-Name 773 779	safety
R3	Caused-By Arg1:T40 Arg2:E34
T65	Eq-Comparison 301 308	history
E38	Eq-Comparison:T65 Temporal-Period:T66
T66	Eq-Temporal-Period 301 308	history
A18	Eq-Temporal-Period-Value T66 past
T67	Eq-Comparison 494 502	Previous
E39	Eq-Comparison:T67 Temporal-Period:T68
T68	Eq-Temporal-Period 494 502	Previous
A19	Eq-Temporal-Period-Value T68 past
T69	Eq-Comparison 578 585	history
E40	Eq-Comparison:T69 Temporal-Period:T70
T70	Eq-Temporal-Period 578 585	history
A20	Eq-Temporal-Period-Value T70 past
T51	Eq-Temporal-Period 614 622	previous
A15	Eq-Temporal-Period-Value T51 past
T71	Study 433 448	investigational
E35	Study:T71 Study-Of:E24
T72	Condition 462 479	Immunocompromised
E41	Condition:T72 Name:T73
T73	Condition-Name 462 479	Immunocompromised
T74	Modifier 394 399	Known
E42	Modifier:T74 Modifies:T42
T75	Assertion 403 412	suspected
E43	Assertion:T75 Asserted:E23
A21	Assertion-Type-Value E43 hypothetical
T76	Or 400 402	or
E44	Or:T76 Arg:E42 Arg2:E43
